HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Infiltrating transitional carcinoma of the bladder. (1st part). Preoperative or neoadjuvant chemotherapy. Our experience with 38 patients followed-up for a prolonged period].

Abstract
Analysis of the evolution of 37 patients treated with neoadjuvant chemotherapy + radical cystectomy and bilateral lymphadenectomy. Patients were followed until death, and survivors between 43 and 68 months. Twenty-six patients died. Twenty of them within 24 months after treatment and 6 after 2 years. Five did not undergo surgery due to fast tumour progression during the interval scheduled for cytostatics administration. Bladder removal was rejected in 5 cases after a significant loco-regional progression was shown by laparotomy. Initially, bladder was preserved in 12 patients after TUR + chemotherapy, and in 8 patients when cCR was observed: 1 died due to a disease unrelated cause. 1 was lost after 16 months with no evidence of vesical cancer or metastasis. 3 presented distant dissemination. 3 are alive and have no evidence of tumour. 1 pCR died of metastasis. 1 cPR required radical cystectomy and died of metastasis. Of the 2 cases defined as sCR, one had to undergo radical cystectomy and remains disease-free while the other one died of metastasis. Radical cystectomy was performed in 15 cases. Three remain tumour-free, 2 were lost. to follow-up and 10 died (3 for disease-unrelated causes and 7 as a consequence of their condition). Nodes affectation were present in 54%. Metastasis was found in 57.3% and 17.3% had local relapse. The pre-operative chemotherapy regime examined has not contributed to prolong the metastasis-free interval in the group of patients studied.
AuthorsA Escudero Barrilero, E Fernández, C Crespo
JournalActas urologicas espanolas (Actas Urol Esp) Vol. 19 Issue 4 Pg. 294-302 (Apr 1995) ISSN: 0210-4806 [Print] Spain
Vernacular TitleCarcinoma transicional infiltrante de vejiga. (1a parte). Quimioterapia preoperatoria o neoadyuvante. Nuestra experiencia con 38 enfermos con seguimiento prolongado.
PMID8815654 (Publication Type: Clinical Trial, English Abstract, Journal Article)
Topics
  • Carcinoma, Transitional Cell (drug therapy, surgery)
  • Chemotherapy, Adjuvant
  • Follow-Up Studies
  • Humans
  • Neoplasm Recurrence, Local (epidemiology)
  • Preoperative Care
  • Time Factors
  • Urinary Bladder Neoplasms (drug therapy, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: